New risk models for hypertrophic cardiomyopathy may improve life-or-death decisions, but validation still matters Hypertrophic cardiomyopathy presents one of the more difficult paradoxes in cardiology. Many patients live for years with mild symptoms...
Continue readingTargeted radiopharmaceutical therapy shows promise against pancreatic cancer in preclinical models Pancreatic cancer has long occupied one of the most difficult places in oncology. It is an aggressive disease, often diagnosed late, and protected by b...
Continue readingUnderstanding cancer risk and making a concrete plan helped sustain gastric screening during the pandemic The COVID-19 pandemic disrupted almost everything that depended on routine, predictability, and trust — including cancer screening. In many plac...
Continue readingAs obesity drugs expand treatment, dietitian-led care may take on a bigger role — but the strength of that recommendation is not confirmed by the supplied evidence The rise of obesity drugs is changing more than the number on the scales. It is also c...
Continue readingObesity drugs may lower blood pressure as they help people lose weight For years, the main argument for obesity drugs was straightforward: they help people lose weight. That alone matters for many patients. But the conversation is shifting. The quest...
Continue readingWeight cycling remains a clinical concern, but the new headline about yo-yo dieting is not confirmed by the supplied evidence Few ideas about weight loss have become as culturally entrenched as the belief that yo-yo dieting — losing weight and then r...
Continue readingNew targeted therapies are expanding options for selected patients with advanced prostate cancer For years, treatment for advanced prostate cancer has carried a frustrating pattern. Even when new drugs arrived, they did not work equally well for ever...
Continue readingWhy breast cancer may become harder to control with age Age enters conversations about breast cancer almost automatically. The older the patient, the greater the concern about prognosis, treatment tolerance, and mortality. But an important question r...
Continue readingNew obesity drugs may help asthma control in some patients, but the evidence is still indirect Asthma has never been a one-size-fits-all disease. In some people it looks mostly like classic allergic airway inflammation. In others, it is entangled wit...
Continue reading
